One platform to run faster, more inclusive trials, together

Inato unites sponsors, research sites, and patients through one AI-powered platform, expanding access, increasing efficiency, and bringing life-changing treatments to more communities around the world.

Built for global impact. Designed for local access.

Inato is the only platform that brings sponsors and sites together to unlock access to clinical trials, faster and more equitably.

Compliance you
can count on.

Our global presence

50+

Countries

5,500+

Sites

25+

Sponsors

Trusted by today’s clinical research leaders

We co-develop our technology with forward-thinking pharma and site leaders to ensure every trial is faster, more efficient, and more inclusive.

One intelligent platform to run better trials

Optimize across your portfolio with insights from sites who can deliver on your trials.

Leverage AI to find the right mix of qualified, motivated sites based on actual capabilities and patient access.

Reduce site burden and accelerate patient enrollment by using AI to automate chart review and pre-screening.

Real impact and proven results

Site Spotlight

Site Spotlight: How one Missouri doctor aims to change rural care

-
Inato
5
min
August 9, 2021
Site Spotlight: How one Missouri doctor aims to change rural care
Sponsors

Asthma Case Study: 181% of Inato’s patient enrollment achieved

Site Spotlight

Site Spotlight: A Georgia-based research center’s mission to uplift the community

-
Inato
5
min
February 16, 2022
Site Spotlight: A Georgia-based research center’s mission to uplift the community
Sponsors

Phase III COPD Case Study: 85% of patients were diverse

Industry Voices

Interview with Robert M. Wachter of UCSF

-
Inato
5
min
November 2, 2022
Interview with Robert M. Wachter of UCSF

Join the global platform driving faster, more accessible trials.